Lyon Joseph Douglas Insider Trades & Stock Holdings

Chief Accounting & Technology Officer · Corcept Therapeutics Incorporated · Latest filing Oct 2, 2026

Lyon Joseph Douglas, Chief Accounting & Technology Officer at Corcept Therapeutics Incorporated has 2 Form 4 trades on file since Oct 1, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($1.16M), net -$1.16M. Latest filing: disposed of 9.19K shares of $CORT on Oct 2, 2026 at $116.13.

Trades on file

2

Open-market bought

$0

Open-market sold

$1.16M

Net open-market

-$1.16M

Latest filing

Oct 2, 2026

All insider trades by Lyon Joseph Douglas

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 2, 2026	$CORT	Sell (Open-market sale) 10b5-1	9.19K	$116.13	$1.07M			+4.3%			Chief Accounting & Technology Officer		—
Oct 1, 2026	$CORT	Sell (Open-market sale) 10b5-1	810	$115.40	$93.47K			+4.0%			Chief Accounting & Technology Officer		—

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Lyon Joseph Douglas traded

• $CORT

Frequently asked questions

Has Lyon Joseph Douglas been buying or selling stock?

Lyon Joseph Douglas has 0 open-market purchases and 2 open-market sales on file, net -$1.16M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Lyon Joseph Douglas's latest insider trade?

disposed of 9.19K shares of $CORT on Oct 2, 2026 at $116.13.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.